LitCovid-sentences  

PMC:7445716 / 15429-72356 JSONTXT 13 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T114 0-156 Sentence denotes All cases with available therapy data (n = 70) except ten [13, 15, 23, 25, 26, 33, 35–37, 41] were treated with intravenous immunoglobulin (IVIG) (Table 1).
T115 157-289 Sentence denotes Conversely, plasma exchange and steroid therapy were performed in ten (four of them received also IVIG) and two cases, respectively.
T116 290-328 Sentence denotes In two patients, no therapy was given.
T117 329-476 Sentence denotes Mechanical or non-invasive ventilation was implemented in 21.4% (15/70) and 7.1% (5/70) patients due to worsening of GBS or COVID-19, respectively.
T118 477-729 Sentence denotes At further observation (n = 68), 72.1% (49/68) patients demonstrated clinical improvement with partial or complete remission, 10.3% (7/68) cases showed no improvement, 11.8% (8/68) still required critical care treatment, and 5.8% (4/68) died (Table 1).
T119 730-833 Sentence denotes Table 1 Summary of clinical findings, results of diagnostic investigations, and outcome in 73 GBS cases
T120 834-984 Sentence denotes Article Country Age Sex GBS clinical picture COVID-19 clinical picture Previous comorbidities GBS diagnosis Level of diagnostic certaintyb GBS variant
T121 985-1117 Sentence denotes Days between COVID-19 symptoms and GBS onset Onset Disease course Autonomic disturbances Respiratory symptoms/failure Time to Nadira
T122 1118-1473 Sentence denotes Agosti et al. [5] Italy 68 M 5 days after LL weakness Bilateral facial palsy, progressive symmetric ascending flaccid tetraparesis, achilles tendon areflexia NA No NA Dry cough associated with fever, dysgeusia, and hyposmia Dyslipidemia, benign prostatic hypertrophy, hypertension, abdominal aortic aneurysm Clinical + CSF + electrophysiology 1 Pure motor
T123 1474-1932 Sentence denotes Alberti et al. [6] Italy 71 M 4 days after (no resolution of pneumonia) LL paraesthesia Ascendant weakness, flaccid tetraparesis, hypoesthesia and paraesthesia in the 4 limbs, generalized areflexia, dyspnea None Yes (concurrent pneumonia) 4 days after symptoms onset (24 h after the admission) Fever (low grade), dyspnea, pneumonia Hypertension, treated abdominal aortic aneurysm, treated lung cancer Clinical + CSF + electrophysiology 1 Classic sensorimotor
T124 1933-2331 Sentence denotes Arnaud et al. [7] France 64 M 23 days after Fast progressive LL weakness Generalized areflexia, severe flaccid proximal paraparesis, decreased proprioceptive length-dependent sensitivity and LL pinprick and light touch hypoesthesia None No 4 days after symptoms onset Fever, cough, diarrhea, dyspnea, severe interstitial pneumonia DM type 2 Clinical + CSF + electrophysiology 1 Classic sensorimotor
T125 2332-2737 Sentence denotes Assini et al. [8] Italy 55 M 20 days after Bilateral eyelid ptosis, dysphagia, dysphonia Masseter weakness, tongue protusion (bilateral hypoglossal nerve paralysis), UL and LL hyporeflexia without muscle weakness, soft palate elevation defect None Yes (concurrent pneumonia) NA Fever, anosmia, ageusia, cough, pneumonia NA Clinical + electrophysiology 2 Classic sensorimotor overlapping with Miller-Fisher
T126 2738-3085 Sentence denotes Assini et al. [8] Italy 60 M 20 days after Distal tetraparesis with right foot drop, autonomic disturbances UL and LL distal weakness, right foot drop, generalized areflexia Gastroplegia, paralytic ileus, loss of blood pressure control Yes (concurrent pneumonia) NA Fever, severe interstitial pneumonia NA Clinical + electrophysiology 2 Pure motor
T127 3086-3501 Sentence denotes Bigaut et al. [9] France 43 M 21 days after UL and LL paraesthesia, distal LL weakness Extension to midthigh and tips of the finger with ataxia, right peripheral facial nerve palsy, generalized areflexia None No 2 days after symptoms onset Cough, asthenia, myalgia in legs, followed by acute anosmia and ageusia with diarrhea, mild interstitial pneumonia NA Clinical + CSF + electrophysiology 1 Classic sensorimotor
T128 3502-3839 Sentence denotes Bigaut et al. [9] France 70 F 10 days after Acute proximal tetraparesis, distal forelimb and perioral paraesthesia Respiratory weakness, loss of ambulation None Yes 3 days after symptoms onset Anosmia, ageusia, diarrhea, asthenia, myalgia, moderate interstitial pneumonia Obesity Clinical + CSF + electrophysiology 1 Classic sensorimotor
T129 3840-4157 Sentence denotes Bracaglia et al. [10] Italy 66 F Unknown (due to asymptomatic infection) Acute proximal and distal tetraparesis, lumbar pain and distal tingling sensation Loss of ambulation, difficulty in speeching and swallowing, generalized areflexia None No NA Asymptomatic None Clinical + electrophysiology 2 Classic sensorimotor
T130 4158-4443 Sentence denotes Camdessanche et al. [11] France 64 M 11 days after UL and LL paraesthesia Ascendent weakness, flaccid tetraparesis, generalized areflexia, dysphagia None Yes 3 days after symptoms onset Fever (high grade), cough, pneumonia None Clinical + CSF + electrophysiology 1 Classic sensorimotor
T131 4444-4710 Sentence denotes Chan et al. [12] Canada 58 M 20 days after home isolation for suspected contact Bilateral facial weakness, dysarthria, feet paraesthesia, LL areflexia NA None No NA Asymptomatic, interstitial pneumonia None Clinical + CSF + electrophysiology 1 Bilateral facial palsy
T132 4711-4728 Sentence denotes with paraesthesia
T133 4729-5165 Sentence denotes Chan et al. [13] USA 68 M 18 days after Gait disturbance, hands and feet paraesthesia LL proximal weakness, absent vibratory and proprioceptive sense at the toes, UL hyporeflexia, LL areflexia, unsteady gait with inability to toe or heel walk, bilateral facial weakness, dysphagia, dysarthria, neck flexion weakness None No 8 days after the onset of symptoms Fever and upper respiratory symptoms NA Clinical + CSF 2 Classic sensorimotor
T134 5166-5479 Sentence denotes Chan et al. [13] USA 84 M 16 days after Hands and feet paraesthesia, progressive gait disturbance Bilateral facial weakness, progressive arm weakness, neuromuscular respiratory failure Yes (not specified autonomic dysfunction) Yes 25 days after the onset of symptoms Fever NA Clinical + CSF 2 Classic sensorimotor
T135 5480-5717 Sentence denotes Coen et al. [14] Switzerland 70 M 6 days after Paraparesis, distal allodynia Generalized areflexia Difficulties in voiding and constipation No NA Dry cough, myalgia, fatigue None Clinical + CSF + 0electrophysiology 1 Classic sensorimotor
T136 5718-6138 Sentence denotes Ebrahimzadeh et al. [15] Iran 46 M 18 days after Pain and numbness in distal LL and UL extremities, ascending weakness in legs Mild peripheral right facial nerve palsy, generalized areflexia None No 7 days after symptoms onset Low-grade fever, sore thorat, dry cough and mild dyspnea, bilateral interstitial pneumonia (concurrent with neurological symptoms) None Clinical + CSF + electrophysiology 1 Classic sensorimotor
T137 6139-6546 Sentence denotes Ebrahimzadeh et al. [15] Iran 65 M 10 days after Progressive ascending LL and UL extremities weakness and paraesthesia Proximal and distal UL and LL weakness, UL hyporeflexia and LL areflexia None No 14 days after symptoms onset History of COVID-19 (symptoms not specified), fine crackles in both lungs (concurrent with neurological symptoms) Hypertension Clinical + electrophysiology 2 Classic sensorimotor
T138 6547-6826 Sentence denotes El Otmani et al. [16] Morocco 70 F 3 days after Weakness and paraesthesia in the 4 limbs Tetraparesis, hypotonia, generalized areflexia, bilateral positive Lasègue sign None No NA Dry cough, pneumonia Rheumatoid arthritis Clinical + CSF + electrophysiology 1 Classic sensorimotor
T139 6827-7209 Sentence denotes Esteban Molina et al. [17] Spain 55 F 14 days after Paraesthesia and weakness in the 4 limbs Lumbar pain, dysphagia, tetraplegia, general areflexia, bilateral facial palsy, lingual and perioral paraesthesia None Yes 3 days after symptoms onset (48 h after the admission) Fever, dry cough and dyspnoea, pneumonia Dyslipidemia Clinical + CSF + electrophysiology 1 Classic sensorimotor
T140 7210-7537 Sentence denotes Farzi et al. [18] Iran 41 M 10 days after Paraesthesia of the feet Tetraparesis, areflexia at the LL and hyporeflexia at the UL, stocking-and-glove hypesthesia and reduced sense of vibration and position None No 7 days after symptoms onset Cough, dyspnea and fever DM type II Clinical + electrophysiology 2 Classic sensorimotor
T141 7538-7764 Sentence denotes Fernández–Domínguez et al. [19] Spain 74 F 15 days after Gait ataxia and generalized areflexia NA NA No NA Respiratory symptoms (not further detailed) Hypertension and follicular lymphoma Clinical + CSF 2 Miller Fisher variant
T142 7765-7865 Sentence denotes Finsterer et al. [20] India 20 M 5 days after NA NA NA NA NA NA NA Clinical + electrophysiology 2 NA
T143 7866-8080 Sentence denotes Frank et al. [21] Brazil 15 M > 5 days after Paraparesis, pain in the LL Rapidly progressive ascending tetraparesis, areflexia NA No NA Fever, intense sweating NA Clinical + electrophysiology 2 Classic sensorimotor
T144 8081-8209 Sentence denotes Gigli et al. [22] Italy 53 M NA Paraesthesia, gait ataxia NA NA NA NA Fever, diarrhea NA Clinical + CSF + electrophysiology 1 NA
T145 8210-8552 Sentence denotes Gutiérrez-Ortiz et al. [23] Spain 50 M 3 days after Vertical diplopia, perioral paraesthesia, gait ataxia Right internuclear ophthalmoparesis and right fascicular oculomotor palsy, ataxia, generalized areflexia None No NA Fever, cough, malaise, headache, low back pain, anosmia, ageusia Bronchial asthma Clinical + CSF 2 Miller Fisher variant
T146 8553-8774 Sentence denotes Gutiérrez-Ortiz et al. [23] Spain 39 M 3 days after Diplopia (bilateral abducens palsy) Generalized areflexia None No NA Diarrhea, low-grade fever None Clinical + CSF 2 Polyneuritis cranialis (GBS–Miller Fisher Interface)
T147 8775-9079 Sentence denotes Helbok et al. [24] Austria 68 M 14 days after Hypoaesthesia and paraesthesia in the LL, proximal weakness, areflexia, stand ataxia Ascending weakness, flaccid tetraparesis, generalized areflexia NA Yes 2 days after symptoms onset (24 h after the admission) Fever, dry cough, myalgia, anosmia and ageusia.
T148 9080-9142 Sentence denotes None Clinical + CSF + electrophysiology 1 Classic sensorimotor
T149 9143-9541 Sentence denotes Hutchins et al. [25] USA 21 M 16 days after Right-sided facial numbness and weakness Bilateral facial palsy, severe dysarthria, bilateral LL weakness , bilateral UL paraesthesia, areflexia NA No 3 days after symptoms onset Fever, cough, dyspnoea, diarrhea, nausea, headache Hypertension, prediabetes, and class I obesity Clinical + CSF + electrophysiology 1 Bilateral facial palsy with paraesthesia
T150 9542-9740 Sentence denotes Juliao Caamaño et al. [26] Spain 61 M 10 days after Facial diplegia No progression None No 1 day after symptoms onset Fever and cough None Clinical + electrophysiology 3 Bilateral facial nerve palsy
T151 9741-9982 Sentence denotes Khalifa et al. [27] Kingdom of Saudi Arabia 11 M 20 days after Gait ataxia, areflexia and paraesthesia in the LL Gradual motor improvement, persistent hyporeflexia NA No NA Acute upper respiratory tract infection, low-grade fever, dry cough.
T152 9983-10043 Sentence denotes NA Clinical + CSF + electrophysiology 1 Classic sensorimotor
T153 10044-10357 Sentence denotes Kilinc et al. [28] The Netherlands 50 M 24 days after Facial diplegia, symmetrical proximal weakness, paraesthesia of distal extremities, gait ataxia, areflexia Progression of limb weakness and inability to walk NA No 11 days after symptoms onset Dry cough None Clinical + electrophysiology 2 Classic sensorimotor
T154 10358-10662 Sentence denotes Lampe et al. [29] Germany 65 M 2 days after Acute right UL and LL weakness causing recurrent falls Right UL paresis, slight paraparesis more pronounced on the right side, generalized hyporeflexia None No 3 days after symptoms onset Fever and dry cough None Clinical + CSF + electrophysiology 1 Pure motor
T155 10663-10970 Sentence denotes Lantos et al. [30] USA 36 M 4 days after Opthalmoparesisa and hypoesthesia below knee Progressive ophthalmoparesis (including initial left III cranial nerve and eventual bilateral VI cranial nerve palsies), ataxia, and hyporeflexia None No NA Fever, chills, and myalgia None Clinical 3 Miller Fisher variant
T156 10971-11356 Sentence denotes Lascano et al. [31] Switzerland 52 F 15 days after (no resolution of pneumonia) Back pain, diarrhea, rapidly progressive tetraparesis, distal paraesthesia Worsening of proximal weakness (tetraplegia), generalized areflexia, ataxia Constipation, abdominal pain Yes 4 days after symptoms onset Dry cough, dysgeusia, cacosmia None Clinical + CSF + electrophysiology 1 Classic sensorimotor
T157 11357-11726 Sentence denotes Lascano et al. [31] Switzerland 63 F 7 days after (no resolution of pneumonia) Limb weakness, pain on the left calf Moderate tetraparesis, LL and left UL areflexia, distal hypoesthesia and paraesthesia None No 5 days after symptoms onset Dry cough, shivering, breathing difficulties, chest pain, odynophagia DM type 2 Clinical + electrophysiology 2 Classic sensorimotor
T158 11727-12194 Sentence denotes Lascano et al. [31] Switzerland 61 F 22 days after LL weakness, dizziness, dysphagia Moderate tetraparesis, bilateral facial palsy, lower limb allodynia, severe hypopallesthesia, areflexia (except for bicipital tendon reflexes) None Yes 4 days after symptoms onset Productive cough, headaches, fever, myalgia, diarrhea, nausea, vomiting, weight loss, recurrent episodes of transient loss of consciousness None Clinical + CSF + electrophysiology 1 Classic sensorimotor
T159 12195-12586 Sentence denotes Manganotti et al. [32] Italy 50 F 16 days after Diplopia and facial paraesthesia Ataxia, diplopia in vertical and lateral gaze, left upper arm dysmetria, generalized areflexia, mild lower facial defects, and mild hypoesthesia in the left mandibular and maxillary branch None Yes (concurrent pneumonia) NA Fever, cough, ageusia, bilateral pneumonia None Clinical + CSF 2 Miller Fisher variant
T160 12587-12841 Sentence denotes Manganotti et al. [33] Italy 72 M 18 days after Tetraparesis UL > LL, LL paraesthesia , generalized areflexia, facial weakness on the right side NA NA No NA Fever, dyspnea, hyposmia and ageusia NA Clinical + CSF + electrophysiology 1 Classic sensorimotor
T161 12842-13053 Sentence denotes Manganotti et al. [33] Italy 72 M 30 days after Tetraparesis LL > UL, paraesthesia, global areflexia NA NA No NA Fever, cough, dyspnea, hyposmia and ageusia NA Clinical + electrophysiology 1 Classic sensorimotor
T162 13054-13319 Sentence denotes Manganotti et al. [33] Italy 49 F 14 days after Ophthalmoplegia, limb ataxia, generalized areflexia, diplopia, facial hypoesthesia, facial weakness NA NA No NA Fever, cough, dyspnea, hyposmia and ageusia NA Clinical + CSF + electrophysiology 1 Miller Fisher variant
T163 13320-13512 Sentence denotes Manganotti et al. [33] Italy 94 M 33 days after LL weakness, generalized hyporeflexia NA NA No NA Fever, cough, gastrointestinal symptoms NA Clinical + electrophysiology 2 Classic sensorimotor
T164 13513-13746 Sentence denotes Manganotti et al. [33] Italy 76 M 22 days after Quadriparesis UL > LL, generalized areflexia, facial weakness, transient diplopia NA NA No NA Fever, cough, dysuria, hyposmia, ageusia NA Clinical + CSF + electrophysiology 1 Pure motor
T165 13747-14033 Sentence denotes Marta-Enguita et al. [34] Spain 76 F 8 days after Back pain and progressive tetraparesis with distal-onset paraesthesia Progressive with dysphagia and cranial nerves involvement, generalized areflexia NA Yes 10 days after symptom onset Cough and fever without dyspnea None Clinical 3 NA
T166 14034-14391 Sentence denotes Mozhdehipanah et al. [35] Iran 38 M 16 days after Progressive LL paraesthesia, facial diplegia, lobal areflexia Mild LL weakness , bulbar symptoms developed Blood pressure instability, tachycardia No 8 days after symptoms onset Upper respiratory infection (no further details) NA Clinical + CSF + electrophysiology 1 Bilateral facial palsy with paraesthesia
T167 14392-14616 Sentence denotes Mozhdehipanah et al. [35] Iran 14 F NA Ascending quadriparesis, UL hyporeflexia, LL areflexia, distal hypoesthesia, ataxia NA NA No NA Upper respiratory infection (no further details) NA Clinical + CSF 2 Classic sensorimotor
T168 14617-14863 Sentence denotes Mozhdehipanah et al. [35] Iran 44 F 26 days after Weakness of LL Tetraparesis, generalized areflexia, symmetrical hypoesthesia NA Yes NA Dry cough, fever, myalgia, progressive dyspnea COPD Clinical + CSF + electrophysiology 1 Classic sensorimotor
T169 14864-15139 Sentence denotes Mozhdehipanah et al. [35] Iran 66 F 30 days after Progressive UL and LL weakness, generalized areflexia, symmetrical hypoesthesia NA No No NA Fever, dry cough, severe myalgia DM, hypertension, and rheumatoid arthritis Clinical + CSF + electrophysiology 1 Classic sensorimotor
T170 15140-15598 Sentence denotes Naddaf et al. [36] USA 58 F 17 days after Progressive paraparesis, imbalance, severe lower thoracic pain without radiation Mild neck flexion weakness, mild/moderate distal UL  and proximal and distal LL  weakness, UL hyporeflexia, LL areflexia, moderately severe length-dependent sensory loss in the feet, ataxic gait None No NA Fever, dysgeusia without anosmia, bilateral interstitial pneumonia None Clinical + CSF + electrophysiology 1 Classic sensorimotor
T171 15599-15834 Sentence denotes Oguz-Akarsu et al. [37] Turkey 53 F Concurrent pneumonia Dysarthria, progressive LL weakness and numbness Ataxia, generalized areflexia None No NA Mild fever (37.5 °C), pneumonia None Clinical + electrophysiology 2 Classic sensorimotor
T172 15835-16188 Sentence denotes Ottaviani et al. [38] Italy 66 F 7 days after (concurrent pneumonia) Flaccid paraparesis, no sensory symptoms Progressively developed proximal weakness in all limbs, dysesthesia, and unilateral facial palsy, generalized areflexia NA Yes 13 days after symptoms onset Fever and cough, pneumonia NA Clinical + CSF + electrophysiology 1 Classic sensorimotor
T173 16189-16479 Sentence denotes Padroni et al. [39] Italy 70 F 23 days after UL and LL paraesthesia, gait difficulties, asthenia Ascendant weakness, tetraparesis, generalized areflexia None Yes 6 days after symptoms onset Fever (38.5 °C), dry cough, pneumonia None Clinical + CSF + Electrophysiology 1 Classic sensorimotor
T174 16480-16754 Sentence denotes Paterson et al. [40] UK 42 M 13 day after Distal limb numbness and weakness, dysphagia Tetraparesis, generalized areflexia, sensory loss NA Yes 16 days after symptom onset Cough, fever dyspnea, diarrhea, anosmia None Clinical + CSF + electrophysiology 1 Classic sensorimotor
T175 16755-17045 Sentence denotes Paterson et al. [40] UK 60 M 1 day before Distal limb numbness and weakness Tetraparesis, generalized areflexia, sensory loss, dysautonomia, facial and bulbar weakness Yes Yes 5 days after symptom onset Headache, ageusia, anosmia NA Clinical + CSF + electrophysiology 1 Classic sensorimotor
T176 17046-17255 Sentence denotes Paterson et al. [40] UK 38 M 21 day after Distal limb numbness, weakness, clumsiness Mild distal weakness, sensory ataxia None No NA Cough, diarrhea NA Clinical + CSF + electrophysiology 1 Classic sensorimotor
T177 17256-17705 Sentence denotes Paybast et al. [41] Iran 38 M 21 days after Acute progressive ascending paraesthesia of distal LL Quadriparesthesia, bilateral facial droop with drooling of saliva and slurred speech, generalized areflexia, swallowing inability, bilaterally absent gag reflex Tachycardia and blood pressure instability No 3 days after symptoms onset Symptoms of upper respiratory tract infection Hypertension Clinical + CSF + electrophysiology 1 Classic sensorimotor
T178 17706-18145 Sentence denotes Paybast et al. [41] Iran 14 F 21 days after Progressive ascending quadriparesthesia, mild LL weakness Mild proximal and distal LL weakness, hypoactive deep tendon reflexes in UL and absent in LL, decreased light touch, position, and vibration sensation in all distal limbs up to ankle and elbow joints, gait ataxia None No 2 days after symptoms onset Symptoms of upper respiratory tract infection None Clinical + CSF 2 Classic sensorimotor
T179 18146-18612 Sentence denotes Pfefferkorn et al. [42] Germany 51 M 14 days after UL and LL weakness, acral paraesthesia Tetraparesis, generalized areflexia, deterioration to an almost complete peripheral locked-in syndrome with tetraplegia, complete sensory loss at 4 limbs, bilateral facial and hypoglossal paresis None Yes 15 days after symptoms onset Fluctuating fever, flu-like symptoms with marked fatigue and dry cough, pneumonia NA Clinical + CSF + electrophysiology 1 Classic sensorimotor
T180 18613-18980 Sentence denotes Rana et al. [43] USA 54 M 14 days after LL paresthesias of LL Ascending tetraparesis, general areflexia, burning sensation diplopia, facial diplegia, mild ophthalmoparesis Resting tachycardia and urinary retention Yes NA Rhinorrhea, odynophagia, fever, chills, and night sweats Hypertension, hyperlipidemia, restless leg syndrome, and chronic back pain, concurrent C.
T181 18981-19053 Sentence denotes Difficile infection Clinical + electrophysiology 2 Miller Fisher variant
T182 19054-19415 Sentence denotes Reyes-Bueno et al. [44] Spain 50 F 15 days after Root-type pain in all four limbs, dorsal and lumbar back pain LL Weakness, ataxia, diplopia, bilateral facial palsy, generalized areflexia Dry mouth, diarrhea and unstable blood pressure No 12 days after symptoms onset Diarrhea, odynophagia and cough NA Clinical + CSF + electrophysiology 1 Miller Fisher variant
T183 19416-19761 Sentence denotes Riva et al. [45] Italy 60+ M 17 days after Progressive limb weakness and distal paresthesia at four limbs Ascending paraparesis with involvement of the cranial nerves (facial diplegia), generalized areflexia None No 10 days after symptoms onset Fever, headache, myalgia, anosmia and ageusia NA Clinical + electrophysiology 2 Classic sensorimotor
T184 19762-20133 Sentence denotes Sancho-Saldaña et al. [46] Spain 56 F 15 days after Unsteadiness and paraesthesia in both hands Lumbar pain and ascending weakness, global areflexia, bilateral facial nerve palsy, oropharyngeal weakness and severe proximal tetraparesis No Yes 3 days after symptoms onset Fever, dry cough and dyspnea, pneumonia NA Clinical + CSF + electrophysiology 1 Classic sensorimotor
T185 20134-20447 Sentence denotes Scheidl et al. [47] Germany 54 F 11 days after Proximal weakness of LL, numbness of 4 limbs Initial worsening of the paraparesis with rapid improvement upon initiation of the treatment, areflexia None No 12 days after symptoms onset Temporary ageusia, None Clinical + CSF + electrophysiology 1 Paraparetic variant
T186 20448-20780 Sentence denotes Sedaghat et al. [48] Iran 65 M 14 days after LL distal weakness Ascending weakness, tetraparesis, facial bilateral palsy, generalized areflexia, LL distal hypoesthesia and hypopallesthesia None No 4 days after symptoms onset Fever, cough and sometimes dyspnea, pneumonia DM type 2 Clinical + electrophysiology 2 Classic sensorimotor
T187 20781-21176 Sentence denotes Sidig et al. [49] Sudan 65 M 5 days after Numbness and weakness in both UL and LL Ascending weakness, bilateral facial paraesthesia and palsy, clumsiness of UL, tetraparesis, slight palatal muscle weakness, areflexia Urinary incontinence Yes NA Low-grade fever, sore throat, dry cough, headache and generalized fatigability DM and Hypertension Clinical + electrophysiology 2 Classic sensorimotor
T188 21177-21585 Sentence denotes Su et al. [50] USA 72 M 6 days after Proximal UL and LL weakness Progression with worsening of the paresis, areflexia, hypoesthesia Hypotension alternating with hypertension and tachycardia Yes 8 days after symptoms onset Mild diarrhea, anorexia and chills without fever or respiratory symptoms Coronary artery disease, hypertension and alcohol abuse Clinical + CSF + electrophysiology 1 Classic sensorimotor
T189 21586-21936 Sentence denotes Tiet et al. [51] United Kingdom 49 M 21 days after Distal LL paraesthesia LL and UL weakness, facial diplegia, distal reduced sensation to pinprick and vibration sense, LL dysesthesia, generalized areflexia None No 4 days after symptoms onset Shortness of breath, headache and cough Sinusitis Clinical + CSF + electrophysiology 1 Classic sensorimotor
T190 21937-22267 Sentence denotes Toscano et al. [52] Italy 77 F 7 days after UL and LL paraesthesia Flaccid tetraplegia, areflexia, facial weakness, dysphagie, tongue weakness None Yes NA Fever, cough, ageusia, pneumonia Previous ischemic stroke, diverticulosis, arterial hypertension, atrial fibrillation Clinical + CSF + electrophysiology 1 Classic sensorimotor
T191 22268-22519 Sentence denotes Toscano et al. [52] Italy 23 M 10 days after Facial diplegia LL paraesthesia, generalized areflexia, sensory ataxia None No 2 days after symptoms onset Fever, pharyngitis NA Clinical + CSF + electrophysiology 1 Bilateral facial palsy with paraesthesia
T192 22520-22762 Sentence denotes Toscano et al. [52] Italy 55 M 10 days after Neck pain, Paresthesias in the 4 limbs, LL weakness Flaccid tetraparesis, areflexia, facial weakness None Yes NA Fever, cough, pneumonia NA Clinical + CSF + electrophysiology 1 Classic sensorimotor
T193 22763-22957 Sentence denotes Toscano et al. [52] Italy 76 M 5 days after Lumbar pain, LL weakness Flaccid tetraparesis, generalized areflexia, ataxia None No 4 days after symptoms onset Cough and hyposmia NA Clinical + CSF+
T194 22958-22998 Sentence denotes Electrophysiology 1 Classic sensorimotor
T195 22999-23252 Sentence denotes Toscano et al. [52] Italy 61 M 7 days after LL weakness and paraesthesia Ascending weakness, tetraplegia, facial weakness, areflexia, dysphagia None Yes NA Cough, ageusia and anosmia, pneumonia NA Clinical + CSF+ electrophysiology 1 Classic sensorimotor
T196 23253-23556 Sentence denotes Velayos Galán et al. [53] Spain 43 M 10 days after Distal weakness and numbness of the 4 limbs, gait ataxia Progression of the weakness with bilateral facial paresis and dysphagia, generalized areflexia NA No 2 days after admission Cough, pneumonia NA Clinical + electrophysiology 2 Classic sensorimotor
T197 23557-23892 Sentence denotes Virani et al. [54] USA 54 M 8 days after LL weakness, numbness Ascending weakness, tetraparesis, areflexia Urinary retention Yes Shortly after presentation in the outpatient clinic (after 2 days of symptoms onset) Fever (102 F), dry cough, pneumonia Clostridium difficile colitis 2 days before GBS onset Clinical 3 Classic sensorimotor
T198 23893-24309 Sentence denotes Webb et al. [55] United Kingdom 57 6 days after Ataxia, progressive limb weakness and foot dysaesthesia, Tetraparesis, generalized areflexia, hypoesthesia in the 4 limbs, hypopallesthesia in LL, dysphagia None Yes 3 days after symptoms onset Mild cough and headache, myalgia and malaise, slight fever, diarrhea, pneumonia Untreated hypertension and psoriasis Clinical + CSF + electrophysiology 1 Classic sensorimotor
T199 24310-24565 Sentence denotes Zhao et al. [56] China 61 F 8 days before LL weakness Ascending weakness, tetraparesis, areflexia, LL distal hypoesthesia None No 4 days after symptoms onset Fever (38·2 °C), dry cough pneumonia NA Clinical + CSF + electrophysiology 1 Classic sensorimotor
T200 24566-24696 Sentence denotes Article COVID-19 diagnosis Blood findings Auto-antibodies and screening for most common GBS causes CSF findings Electrophysiology:
T201 24697-24801 Sentence denotes Neuropathy type and GBS electrophysiologic subtype MRI (brain and spinal) Management and therapy Outcome
T202 24802-24814 Sentence denotes GBS COVID-19
T203 24815-24899 Sentence denotes Agosti et al. [5] RT-PCR + chest CT Thrombocytopenia (101 × 109 /L, reference value:
T204 24900-24967 Sentence denotes 125–300 × 109 /L), lymphocytopenia (0.48 × 109 /L, reference value:
T205 24968-25260 Sentence denotes 1.1–3.2 × 109 /L) Negative ANA, anti-DNA, c-ANCA, p-ANCA, negative screening for Campylobacter jejuni, Mycoplasma pneumoniae, Salmonella enterica, CMV, HSV 1 and 2, VZV, influenza virus A and B, HIV, normal B12 and serum protein electrophoresis Increased total protein (98 mg/dl), cell count:
T206 25261-25282 Sentence denotes 2/106 L Demyelinating
T207 25283-25406 Sentence denotes AIDP NA IVIG 400 mg/kg/day (5 days) Antiviral drugs (not specifically mentioned) Improvement, discharged home after 30 days
T208 25407-25535 Sentence denotes Alberti et al. [6] RT-PCR + chest CT NA NA Increased total protein (54 mg/dl), 9 cells/µl, negative SARS-CoV-2 PCR Demyelinating
T209 25536-25700 Sentence denotes AIDP NA IVIG 400 mg/kg (5 days) + mechanical invasive ventilation Lopinavir/ritonavir, hydroxychloroquine 24 h after admission, death because of respiratory failure
T210 25701-26004 Sentence denotes Arnaud et al. [7] RT-PCR + chest CT NA Negative anti-ganglioside and antineural antibodies, negative Campylobacter Jejuni, HIV, syphilis, CMV, EBV serology Increased total protein (1.65 g/L), no pleyocitosis, negative oligoclonal bands, negative SARS-CoV-2 PCR, negative EBV and CMV RT-PCR Demyelinating
T211 26005-26105 Sentence denotes AIDP NA IVIG 400 mg/kg (5 days) Hydroxychloroquin, cefotaxime, azithromycine Progressive improvement
T212 26106-26395 Sentence denotes Assini et al. [8] RT-PCR Lymphocytopenia, increased LDH and inflammation markers; low serum albumin (2.9 mg/dL) NA Normal total protein level, increased IgG/albumin ratio (233), negative SARS-CoV-2 PCR, presence of oligoclonal bands (both in serum and CSF) Demyelinating with sural sparing
T213 26396-26641 Sentence denotes AIDP Brain: no pathological findings IVIG 400 mg/kg (5 days) Hydroxychloroquine, arbidol, ritonavir and lopinavir + mechanical invasive ventilation 5 days after IVIG, improvement of swallowing, speech, tongue motility, eyelid ptosis and strength
T214 26642-26990 Sentence denotes Assini et al. [8] RT-PCR + chest CT Lymphocytopenia, increased LDH and GGT, leucocytosis, low serum albumin (2.6 mg/dL) Negative anti-ganglioside antibodies Normal total protein level, increased IgG/albumin ratio (170), negative SARS-CoV-2 PCR, presence of oligoclonal bands (both in serum and CSF) Motor sensory axonal, muscular neurogenic changes
T215 26991-27222 Sentence denotes AMSAN NA IVIG 400 mg/kg (5 days) Hydroxychloroquine, antiretroviral therapy, tocilizumab + tracheostomy and assisted ventilation 5 days after IVIG, improvement of vegetative symptoms, persistence of hyporeflexia and right foot drop
T216 27223-27418 Sentence denotes Bigaut et al. [9] RT-PCR + chest CT Normal blood count, negative CRP Negative anti-ganglioside antibodies, negative HIV, Lyme and syphilis serology Increased total protein (0.95 g/L), cell count:
T217 27419-27467 Sentence denotes 1 × 106/L, negative SARS-CoV-2 PCR Demyelinating
T218 27468-27480 Sentence denotes AIDP Spinal:
T219 27481-27680 Sentence denotes Radiculitis and plexitis on both brachial and lumbar plexus; multiple cranial neuritis (in III, VI, VII, and VIII nerves) IVIG 400 mg/kg (5 days) + non-invasive ventilation NA Progressive improvement
T220 27681-27814 Sentence denotes Bigaut et al. [9] RT-PCR + chest CT Increased CRP Negative anti-ganglioside antibodies Increased total protein (1.6 g/L), cell count:
T221 27815-27863 Sentence denotes 6 × 106/L, negative SARS-CoV-2 PCR Demyelinating
T222 27864-27927 Sentence denotes AIDP NA IVIG 400 mg/kg (5 days) NA Slow progressive improvement
T223 27928-28379 Sentence denotes Bracaglia et al. [10] RT-PCR (normal chest CT) Elevated CPK (461 U/L, normal < 145), CRP 5,65 mg/dL (normal < 0.5), lymphocyto- penia (0·68 × 109/L, normal 1·10–4), mild increase of LDH (284 U/L, normal < 248), GOT and GPT (549 and 547 U/L, normal < 35), elevation of IL-6 (11 pg/mL, normal < 5.9) Negative anti-ganglioside antibodies; negative microbiologic testing on CSF and serum for HSV1-2, EBV, VZV, CMV, HIV, Mycoplasma Pneumoniae and Borrelia.
T224 28380-28441 Sentence denotes Increased total protein (245 mg/dL) and increased cell count:
T225 28442-28494 Sentence denotes 13 cells/mm3, polymorphonucleate 61.5% Demyelinating
T226 28495-28633 Sentence denotes AIDP NA IVIG 400 mg/kg (5 days) Hydroxychloroquine, ritonavir, darunavir Improvement of UL and LL weakness, development of facial diplegia
T227 28634-28942 Sentence denotes Camdessanche et al. [11] RT-PCR + chest CT NA Negative anti-gangliosides antibodies; negative screening for Campylobacter jejuni, Mycoplasma pneumoniae, Salmonella enterica, CMV, EBV, HSV1-2, VZV, Influenza virus A & B, HIV, and hepatitis E Increased total protein (1.66 g/L), normal cell count Demyelinating
T228 28943-29125 Sentence denotes AIDP NA IVIG 400 mg/kg (5 days) + mechanical invasive ventilation Oxygen therapy, paracetamol, low molecular weight heparin, lopinavir/ritonavir 400/100 mg twice a day for 10 days NA
T229 29126-29291 Sentence denotes Chan et al. [12] RT-PCR + chest CT Persistent thrombocytosis (maximum PC 688 ×109/L), elevated d-dimer (1.47 mg/L) NA Increased total protein (1.00 g/L), cell count:
T230 29292-29349 Sentence denotes 4 × 106/L (normal), negative SARS-CoV-2 PCR Demyelinating
T231 29350-29532 Sentence denotes AIDP Brain: bilateral intracranial facial nerve enhancement IVIG 400 mg/kg (5 days) Empiric azithromycin and ceftriaxone Slight improvement of facial weakness, unchanged paraesthesia
T232 29533-29646 Sentence denotes Chan et al. [13] RT-PCR NA Negative anti-gangliosides antibodies Increased total protein (226 mg/dL), leucocytes:
T233 29647-29668 Sentence denotes 3 cells/mm3, glucose:
T234 29669-29870 Sentence denotes 56 mg/dL, negative SARS-CoV-2 PCR NA Lumbosacral spine: no pathological findings 5 sessions of plasmapheresis NA Resolution of dysphagia, ambulation with minimal assistance 28 days after symptoms onset
T235 29871-29977 Sentence denotes Chan et al. [13] RT-PCR NA Elevated GM2 IgG/IgM antibodies Increased total protein (67 mg/dL), leucocytes:
T236 29978-30248 Sentence denotes 1 cells/mm3, glucose 58 mg/dL, negative SARS-CoV-2 PCR NA NA Mechanical invasive ventilation + 5 sessions of plasmapheresis (without benefit on ventilation) + IVIG NA Persistence of quadriparesis with intermittent autonomic dysfunction, slowly weaned from the ventilator
T237 30249-30505 Sentence denotes Coen et al. [14] RT-PCR + serology Normal (not specified) Negative anti-gangliosides antibodies; negative meningitis/encephalitis panel Albuminocytological dissociation, no intrathecal IgG synthesis, negative SARS-CoV-2 PCR Demyelinating with sural sparing
T238 30506-30520 Sentence denotes AIDP Brain: NA
T239 30521-30599 Sentence denotes Spinal: no pathological findings IVIG 400 mg/kg (5 days) NA Rapid improvement.
T240 30600-30632 Sentence denotes From day 11 from hospitalisation
T241 30633-30647 Sentence denotes Rehabilitation
T242 30648-31036 Sentence denotes Ebrahimzadeh et al. [15] RT-PCR + chest CT Normal CRP (5 mg/L), normal serum protein immunoelectrophoresis Negative anti-GQ1b antibodies, negative screening for Campylobacter jejuni, HIV, EBV, CMV, influenza virus (type A and B), HCV, non-reactive VDRL Increased total protein (78 mg/dL), normal cell count (erythrocyte = 0/mm3, leukocyte = 4/mm3), normal glucose (70 mg/dL) Demyelinating
T243 31037-31073 Sentence denotes AIDP Brain: no pathological findings
T244 31074-31201 Sentence denotes Spinal: no pathological findings None Hydroxychloroquine for 5 days Improvement of muscle strength to near normal after 16 days
T245 31202-31483 Sentence denotes Ebrahimzadeh et al. [15] RT-PCR + chest CT Slightly elevated CRP (34 mg/L), normal serum protein immunoelectrophoresis Negative anti-GQ1b antibodies, negative screening for Campylobacter jejuni, HIV, EBV, CMV, influenza virus (type A and B), HCV, non-reactive VDRL NA Demyelinating
T246 31484-31563 Sentence denotes AIDP NA IVIG NA Improvement of muscle strength in all extremities after 14 days
T247 31564-31706 Sentence denotes El Otmani et al. [16] RT-PCR + chest CT Lymphocytopenia (520/ml) NA Increased total protein (1 g/L), normal cell count, negative PCR assay for
T248 31707-31738 Sentence denotes SARS-CoV-2 Motor sensory axonal
T249 31739-31929 Sentence denotes AMSAN NA IVIG 400 mg/kg/day (5 days) Hydroxychloroquine 600 mg/day; azithromycin 500 mg at the first day, then 250 mg per day At week 1 from admission no significant neurological improvement
T250 31930-32018 Sentence denotes Esteban Molina et al. [17] RT-PCR + chest X-ray Leucocyte 7400/mm3, lymphocyte 2400/mm3.
T251 32019-32030 Sentence denotes Hb 14 g/dl.
T252 32031-32065 Sentence denotes PC 408,000/mm3, d-Dimer 556 ng/ml.
T253 32066-32210 Sentence denotes Ferritin 544 ng/ml, CRP 2.04 mg/dl, Fibrinogen 6.8 g/dl Negative bacteriological and viral tests Increased total protein (86 mg/dL), cell count:
T254 32211-32232 Sentence denotes 3x106/L Demyelinating
T255 32233-32425 Sentence denotes AIDP Brain: leptomeningeal enhancement in midbrain and cervical spine IVIG 400 mg/kg/day (5 days) Hydroxychloroquine, azithromycin, ceftriaxon Motor improvement but persistence of paraesthesia
T256 32426-32504 Sentence denotes Farzi et al. [18] RT-PCR + chest CT Lymphopenia (WBC:5.9 × 109/L, neutrophils:
T257 32505-32582 Sentence denotes 85%, lymphocyte:15%), elevated levels of CRP, ESR 69 mm/h NA NA Demyelinating
T258 32583-32703 Sentence denotes AIDP NA IVIG (2 g/kg over 5 days) Lopinavir/ritonavir and hydroxychloroquine Improvement after 3 days, favorable outcome
T259 32704-32903 Sentence denotes Fernández–Domínguez et al. [19] RT-PCR NA Negative anti-GD1b antibodies, negative other anti-ganglioside antibodies Increased total protein (110 mg/dL), albuminocytological dissociation Demyelinating
T260 32904-33004 Sentence denotes NA Brain: no pathological findings IVIG 20 g/day (5 days) Hydroxychloroquine, lopinavir/ritonavir NA
T261 33005-33045 Sentence denotes Finsterer et al. [20] NA NA NA NA Axonal
T262 33046-33070 Sentence denotes AMAN NA IVIG NA Recovery
T263 33071-33395 Sentence denotes Frank et al. [21] RT-PCR, + serology (IgG and IgM) WBC and CRP normal Negative hepatitis B and C, HIV and VDRL tests Two CSF analysis 2 weeks apart, both showing normal cell count and CSF biochemistry, negative SARS-CoV-2 PCR, negative PCR for HSV1, HSV2, CMV, EBV, VZV; Zika virus; Dengue virus and Chikungunya virus Axonal
T264 33396-33432 Sentence denotes AMAN Brain: no pathological findings
T265 33433-33576 Sentence denotes Spinal: no pathological findings IVIG 400 mg/kg/day (5 days) Methylprednisolone, azithromycin, albendazole Some improvement, weakness persisted
T266 33577-33779 Sentence denotes Gigli et al. [22] Chest CT + serology (negative RT-PCR) NA Negative anti-ganglioside antibodies, negative PCR for influenza A and B viruses (nasal swab) Increased total protein (192.8 mg/L), leucocytes:
T267 33780-33859 Sentence denotes 2.6 cells/µL, positive Ig for SARS-CoV-2, negative SARS-CoV-2 PCR Demyelinating
T268 33860-33876 Sentence denotes AIDP NA NA NA NA
T269 33877-34085 Sentence denotes Gutiérrez-Ortiz et al. [23] RT-PCR Lymphocytes 1000 cells/UI, CRP 2.8 mg/dl Positive anti-GD1b antibodies, other anti-ganglioside antibodies negative Increased total protein (80 mg/dl), no leucocytes, glucose
T270 34086-34225 Sentence denotes 62 mg/dl, negative SARS-CoV-2 PCR NA NA IVIG 400 mg/kg (5 days) NA After 2 weeks from admission complete resolution except anosmia, ageusia
T271 34226-34331 Sentence denotes Gutiérrez-Ortiz et al. [23] RT-PCR Leucopenia (3100 cells/µl) NA Increased total protein (62 mg/dl), WBC:
T272 34332-34362 Sentence denotes 2/μl (all monocytes), glucose:
T273 34363-34537 Sentence denotes 50 mg/dl, negative SARS-CoV-2 PCR NA NA None Paracetamol 2 weeks later complete neurological recovery with no ageusia, complete eye movements, and normal deep tendon reflexes
T274 34538-34623 Sentence denotes Helbok et al. [24] Chest CT + serology (repeated negative RT-PCR) WBC 8.1G/L (normal:
T275 34624-34661 Sentence denotes 4.0–10.0G/L), CRP 2.3 mg/dL, (normal:
T276 34662-34713 Sentence denotes 0.0–0.5 mg/dL), fibrinogen level 650 mg/dL (normal:
T277 34714-34750 Sentence denotes 210–400 mg/dL), LDH 276 U/L (normal:
T278 34751-34999 Sentence denotes 100–250 U/L), erythrocyte sedimentation rate 55 mm/1 h Negative PCR for CMV, EBV, influenza virus A/B, Respiratory Syncytial Virus and IgM antibodies for Chlamydia pneumoniae and Mycoplasma pneumoniae Increased total protein (64 mg/dl), cell count:
T279 35000-35213 Sentence denotes 2 cells/mm3, serum/ CSF glucose ratio of 0.83, negative SARS-CoV-2 PCR, positive anti-SARS-CoV-2 antibodies (not determined if intrathecal synthesis or passive transfer from blood) Demyelinating with sural sparing
T280 35214-35423 Sentence denotes AIDP Spinal: no pathological findings IVIG 30 g + plasma exchange (4 cycles) + mechanical invasive ventilation None Improvement of muscle forces with recovery of mobility without significant help after 8 weeks
T281 35424-35538 Sentence denotes Hutchins et al. [25] RT-PCR + chest CT Lymphopenia (absolute lymphocyte count of 0.7 K/mm3) Serum HSV IgG and IgM.
T282 35539-36092 Sentence denotes Respiratory viral panel PCR negative Negative GM1, GD1b, and GQ1b IgG and IgM), aquaporin-4 receptor (IgG), HIV 1/2, HSV 1/2 (IgG and IgM), CMV (IgM), Mycoplasma pneumoniae (IgG and IgM), Borrelia burgdorferi (IgG and IgM), Bartonella species (IgG and IgM), and syphilis (Venereal Disease Research Laboratory test) Increased total protein (49 mg/dL), normal glucose levels (65 mg/dL), no leukocytes Mixed demyelinating and axonal EMG subtype unknown Brain: enhancement of the facial and abducens nerves bilaterally, as well as the right oculomotor nerve
T283 36093-36194 Sentence denotes Spinal: no pathological findings Plasma exchange (5 cycles) NA Discharged to inpatient rehabilitation
T284 36195-36302 Sentence denotes Juliao Caamaño et al. [26] RT-PCR NA NA Normal total protein (44 mg/dL), no pleocytosis Absent blink-reflex
T285 36303-36480 Sentence denotes EMG subtype unknown Brain: no pathological findings Oral prednisolone Hydroxychloroquine and lopinavir/ritonavir for 14 days Minimal improvement of muscle weakness after 2 weeks
T286 36481-37015 Sentence denotes Khalifa et al. [27] RT-PCR + chest X-ray + chest CT WBC 5.5 × 103, PC 356 × 103, CRP 0.5 mg/dL (normal 0.0–0.5), serum ferritin 87.3 ng/ml (normal 12.0–150.0), elevated d-Dimer levels 0.72 mg/L (0.00–0.49) Negative screening for:  influenza A and B viruses; influenza A virus subtypes H1, H3, and H5 including subtype H5N1 of the Asian lineage; parainfluenza virus types 1, 2, 3, and 4; respiratory syncytial virus types A and B; adenovirus; metapneumovirus; rhinovirus; enterovirus; Coronavirus 229E, HKU1, NL63, and OC43 Cell count:
T287 37016-37074 Sentence denotes 5 mm3, increased total protein (316.7 mg/dL) Demyelinating
T288 37075-37111 Sentence denotes AIDP Brain: no pathological findings
T289 37112-37313 Sentence denotes Spinal: enhancement of the cauda equina nerve roots IVIG 1 g/kg (2 days) Paracetamol, azithromycin, hydroxychloroquine Discharge to home after 15 days with clinical and electrophysiological improvement
T290 37314-37571 Sentence denotes Kilinc et al. [28] Fecal PCR + serology NA Negative anti-GQ1b antibodies, serologic tests on Borrelia burgdorferi, syphilis, Campylobacter jejuni, CMV, hepatitis E, Mycoplasma pneumoniae and CMV Normal cell count, normal proteins Predominantly demyelinating
T291 37572-37696 Sentence denotes AIDP Brain: no pathological findings IVIG 2 g/kg (5 days) None Persistence of mild symptoms at the discharge (after 14 days)
T292 37697-37950 Sentence denotes Lampe et al. [29] RT-PCR (negative chest X-ray) Slightly increased CRP (1.92 mg/dL) Negative anti-ganglioside antibodies; negative influenza and respiratory syncytial virus Increased total protein (56 mg/dL), normal cell count (2 cells/μL) Demyelinating
T293 37951-38112 Sentence denotes AIDP NA IVIG 400 mg/kg (5 days) None Improvement of GBS symptoms with persistence of generalized areflexia except for left biceps reflex, discharge after 12 days
T294 38113-38361 Sentence denotes Lantos et al. [30] RT-PCR NA GM1 antibodies in the equivocal range NA NA Brain: enlargement, prominent enhancement with gadolinium, and T2 hyperintense signal of the left cranial nerve III IVIG Hydroxychloroquine Improvement, discharge after 4 days
T295 38362-38601 Sentence denotes Lascano et al. [31] RT-PCR + chest X-ray + positive IgM (IgG positivity 2 weeks later) WBC 8900 cells/mm3; lymphocytes 1200 cells/mm3; PC 45,500 cells/mm3 Negative anti-ganglioside antibodies Increased total protein (60 mg/dL), leucocytes:
T296 38602-38651 Sentence denotes 3 cells/μL, negative SARS-CoV-2 PCR Demyelinating
T297 38652-38738 Sentence denotes AIDP Spinal: no nerve root gadolinium enhancement IVIG 400 mg/kg (5 days) + mechanical
T298 38739-38801 Sentence denotes invasive ventilation Azithromycin Improvement of tetraparesis.
T299 38802-38835 Sentence denotes Able to stand up with assistance.
T300 38836-38992 Sentence denotes Lascano et al. [31] RT-PCR + chest X-ray WBC 3300 cells/mm3; lymphocytes 800 cells/mm3; PC 119,000 cells/mm3 NA Normal total protein (40 mg/dl), cell count:
T301 38993-39081 Sentence denotes 2 cells/μL Mixed demyelinating (conduction blocks) and axonal with sural sparing pattern
T302 39082-39191 Sentence denotes Predominantly AIDP NA IVIG 400 mg/kg (5 days) Amoxicillin, clarithromycin Dismissal with full motor recovery.
T303 39192-39243 Sentence denotes Persistence of LL areflexia and distal paraesthesia
T304 39244-39404 Sentence denotes Lascano et al. [31] RT-PCR + chest X-ray WBC 4000 cells/mm3; lymphocytes 600 cells/mm3; PC 322,000 cells/mm3 NA Increased total protein (140 mg/dL), cell count:
T305 39405-39481 Sentence denotes 4 cells/μL, negative SARS-CoV-2 PCR Demyelinating with sural sparing pattern
T306 39482-39518 Sentence denotes AIDP Brain: no pathological findings
T307 39519-39667 Sentence denotes Spinal cord: lumbosacral nerve root enhancement IVIG 400 mg/kg (5 days) Amoxicillin Improvement of tetraparesis and ability to walk with assistance.
T308 39668-39723 Sentence denotes Persistence of neuropathic pain and distal paraesthesia
T309 39724-40238 Sentence denotes Manganotti et al. [32] RT-PCR + chest CT NA Negative anti-ganglioside antibodies negative serum anti-HIV, anti-HBV, anti-HCV antibodies Increased total protein (74.9 mg/dL), negative CSF PCR for bacteria, fungi, Mycobacterium tuberculosis, Herpes viruses, Enteroviruses, Japanese B virus and Dengue viruses NA Brain: no pathological findings IVIG 400 mg/kg (5 days) Lopinavir/ritonavir, hydroxychloroquine, antibiotic therapy, oxygen support (35%) Resolution of all symptoms except for minor hyporeflexia at the LL
T310 40239-40274 Sentence denotes Manganotti et al. [33] RT-PCR IL-1:
T311 40275-40307 Sentence denotes 0.2 pg/ml (< 0.001 pg/ml), IL-6:
T312 40308-40342 Sentence denotes 113.0 pg/ml (0.8–6.4 pg/ml), IL-8:
T313 40343-40378 Sentence denotes 20.0 pg/ml (6.7–16.2 pg/ml), TNF-α:
T314 40379-40567 Sentence denotes 16.0 pg/ml (7.8–12.2 pg/ml) Negative anti-ganglioside antibodies, negative HIV, HBV, HCV negative serological tests for autoimmune disorders Increased total protein (52 mg/dl), leucocytes:
T315 40568-40617 Sentence denotes 1 cell/mm3, negative SARS-CoV-2 PCR Demyelinating
T316 40618-40796 Sentence denotes AIDP NA IVIG 400 mg/kg/day (5 days) Hydroxychloroquine, oseltamivir, darunavir, methylprednisolone and tocilizumab + mechanical invasive ventilation Improvement of motor symptoms
T317 40797-40832 Sentence denotes Manganotti et al. [33] RT-PCR IL-1:
T318 40833-40865 Sentence denotes 0.5 pg/ml (< 0.001 pg/ml), IL-6:
T319 40866-40898 Sentence denotes 9.8 pg/ml (0.8–6.4 pg/ml), IL-8:
T320 40899-40935 Sentence denotes 55.0 pg/ml (6.7–16.2 pg/ml), TNF- α:
T321 40936-41121 Sentence denotes 16.0 pg/ml (7.8–12.2 pg/ml) Negative anti-ganglioside antibodies, negative HIV, HBV, HCV negative serological tests for autoimmune disorders Normal total protein (40 mg/dl), leucocytes:
T322 41122-41394 Sentence denotes 1 cell/mm3, negative SARS-CoV-2 PCR Mixed demyelinating and axonal   EMG subtype unknown Brain: no pathological findings IVIG 400 mg/kg/day (5 days) Hydroxychloroquine, lopinavir/ritonavir, methylprednisolone + mechanical invasive ventilation Improvement of motor symptoms
T323 41395-41587 Sentence denotes Manganotti et al. [33] RT-PCR NA Negative anti-ganglioside antibodies, negative HIV, HBV, HCV negative serological tests for autoimmune disordes Increased total protein (72 mg/dL), leucocytes:
T324 41588-41644 Sentence denotes 5 cell/mm3, negative SARS-CoV-2 PCR Mainly demyelinating
T325 41645-41795 Sentence denotes Predominantly AIDP Brain: no pathological findings IVIG 400 mg/kg/day (5 days) Hydroxychloroquine, lopinavir/ritonavir, methylprednisolone Improvement
T326 41796-41955 Sentence denotes Manganotti et al. [33] RT-PCR NA NA NA Mixed demyelinating and axonal  EMG subtype unknown NA Methylprednisolone 60 mg for 5 days Methylprednisolone Stationary
T327 41956-41991 Sentence denotes Manganotti et al. [33] RT-PCR IL-1:
T328 41992-42024 Sentence denotes 0.2 pg/ml (< 0.001 pg/ml), IL-6:
T329 42025-42058 Sentence denotes 32.7 pg/ml (0.8–6.4 pg/ml), IL-8:
T330 42059-42096 Sentence denotes 17.8 pg/ml (6.7–16.2 pg/ml), TNF- α :
T331 42097-42132 Sentence denotes 11.1 pg/ml (7.8–12.2 pg/ml), IL-2R:
T332 42133-42174 Sentence denotes 1203.0 pg/ml (440.0–1435.0 pg/ml), IL-10:
T333 42175-42354 Sentence denotes 4.6 (1.8–3.8 pg/ml) Negative anti-ganglioside antibodies, negative HIV, HBV, HCV negative serological tests for autoimmune disordes Increased total protein (53 mg/dL), leucocytes:
T334 42355-42643 Sentence denotes 2 cell/mm3, negative SARS-CoV-2 PCR Mixed demyelinating and axonal  EMG subtype unknown NA IVIG 400 mg/kg/day (5 days) Hydroxychloroquine, lopinavir/ritonavir, methylprednisolone, meropenem, linezolid, clarithromycin, fluconazole, doxycycline + mechanical invasive ventilation Improvement
T335 42644-42761 Sentence denotes Marta-Enguita et al. [34] RT-PCR + chest CT Thrombocytopenia, d-Dimer elevation NA NA NA NA NA NA Death after 10 days
T336 42762-42964 Sentence denotes Mozhdehipanah et al. [35] RT-PCR (negative chest CT) Normal WBC, CRP and ESR NA Increased total protein (139 mg/dL), normal cell count, negative CSF HSV serology and gram stain and culture Demyelinating
T337 42965-43097 Sentence denotes AIDP NA Plasma exchange (5 cycles) NA Significant improvement of muscle weakness after 3 weeks, persistence of mild bifacial paresis
T338 43098-43289 Sentence denotes Mozhdehipanah et al. [35] RT-PCR Normal WBC, CRP and ESR NA Albuminocytological dissociation NA NA IVIG 400 mg/kg/day (5 days) NA Complete recovery, except for the persistence of hyporeflexia
T339 43290-43480 Sentence denotes Mozhdehipanah et al. [35] RT-PCR + chest CT Leucocytosis lymphopenia, elevated ESR and CRP NA Increased total protein (57 mg/dL), normal cell count and glucose (not further specified) Axonal
T340 43481-43612 Sentence denotes AMSAN NA IVIG 400 mg/kg/day (3 days) Hydroxy chloroquine, lopinavir/ ritonavir Death after 3 days from starting treatment with IVIG
T341 43613-43811 Sentence denotes Mozhdehipanah et al. [35] RT-PCR + chest CT Leucocytosis, lymphopenia, elevated ESR and CRP NA Increased total protein (89 mg/dL), normal cell count and glucose (not further specified) Demyelinating
T342 43812-43925 Sentence denotes AIDP NA IVIG 400 mg/kg/day (5 days) Hydroxy chloroquine, lopinavir/ ritonavir No significant clinical improvement
T343 43926-43982 Sentence denotes Naddaf et al. [36] Positive SARS-CoV-2 IgG (index value:
T344 43983-44415 Sentence denotes 8.2, normal < 0.8) and IgA + chest CT (negative RT-PCR) Normal completed blood count, elevated d-dimer (690 ng/mL), ferritin (575 mcg/L), ESR (26 mm/h), alanine aminotransferase (73 U/L) Negative anti-ganglioside antibodies negative HIV, syphilis, West Nile virus, Lyme disease testing, EBV and CMV serology consistent with remote infection, negative paraneoplastic evaluation Increased total protein (273 mg/dL), total cells count:
T345 44416-44549 Sentence denotes 2/mm3, negative CSF SARS-CoV-2 RT-PCR, negative meningitis/encephalitis panel, negative oligoclonal bands and IgG index Demyelinating
T346 44550-44745 Sentence denotes AIDP Spine: smooth enhancement of the cauda equine roots Plasma exchange (5 sessions) Hydroxy chloroquine, zinc, methylprednisolone 40 mg bid for 5 days Improvement of motor and gait examination.
T347 44746-44801 Sentence denotes Persistence of slight ataxia without requiring gait aid
T348 44802-45039 Sentence denotes Oguz-Akarsu et al. [37] RT-PCR + chest MRT + chest CT Mild neutropenia (1.49 cells/µL) and a high monocyte percentage (19.77) HIV test negative Normal total protein (32.6 mg/dL) with no leucocytes Demyelinating with sural sparing pattern
T349 45040-45380 Sentence denotes AIDP Cervical and lumbar and spine: asymmetrical thickening and hyperintensity of post-ganglionic roots supplying the brachial and lumbar plexuses in STIR sequences Plasma exchange (five sessions, one every other day) Hydroxychloroquine, azithromycin Marked neurological improvement after 2 weeks and she was able to walk without assistance
T350 45381-45549 Sentence denotes Ottaviani et al. [38] RT-PCR + chest CT Lymphopenia, increased d-dimer, CRP and CK Negative anti-ganglioside antibodies Increased total protein (108 mg/dL), cell count:
T351 45550-45581 Sentence denotes 0 cells/μL Mainly demyelinating
T352 45582-45714 Sentence denotes Predominantly AIDP NA IVIG 400 mg/kg (5 days) Lopinavir/ritonavir, hydroxychloroquine Progressive worsening with multi-organ failure
T353 45715-46035 Sentence denotes Padroni et al. [39] RT-PCR + chest CT WBC 10.41 × 109/L (neutrophils 8.15 × 109/L), normal d-dimer Negative screening for Mycoplasma pneumonia, CMV, Legionella pneumophila, Streptococcus pneumoniae, HSV, VZV, EBV, HIV-1, Borrelia burgdorferi; auto-antibodies not performed Increased total protein (48 mg/dl), cell count:
T354 46036-46066 Sentence denotes 1 × 106/L Motor sensory axonal
T355 46067-46202 Sentence denotes AMSAN NA IVIG 400 mg/kg (5 days) + mechanical invasive ventilation NA At day 6 from admission: ICU with mechanical invasive ventilation
T356 46203-46344 Sentence denotes Paterson et al. [40] Definite diagnosis (not specified) (normal chest CT) Increased neutrophils and CRP NA Increased total protein (0.5 g/L),
T357 46345-46356 Sentence denotes leucocytes:
T358 46357-46388 Sentence denotes 3 cells/μL (0–5), Demyelinating
T359 46389-46558 Sentence denotes AIDP NA IVIG + mechanical invasive ventilation None 17 days of hospitalisation, at discharge able to walk 5 m (across an open space) but incapable of manual work/running
T360 46559-46698 Sentence denotes Paterson et al. [40] Definite diagnosis (not specified) (normal chest CT) Increased CRP and fibrinogen NA Increased total protein (0.6 g/L)
T361 46699-46710 Sentence denotes leucocytes:
T362 46711-46772 Sentence denotes 2 cells/μL (0-5), Glucose 3.4 (mmol/L; 2.2-4.2) Demyelinating
T363 46773-46925 Sentence denotes AIDP Brain: no pathological findings IVIG Mechanical invasive ventilation 46 days (ongoing) of hospitalisation, still critical and requiring ventilation
T364 46926-47061 Sentence denotes Paterson et al. [40] Definite diagnosis (not specified) (normal chest CT) Not significant findings NA Increased total protein (0.9 g/L)
T365 47062-47137 Sentence denotes leucocytes: < 1 cells/μL (0-5), Glucose 3.7 (mmol/L; 2.2-4.2) Demyelinating
T366 47138-47296 Sentence denotes AIDP Brain: no pathological findings IVIG NA 7 days (ongoing) of hospitalisation, able to walk 5 m (across an open space) but incapable of manual work/running
T367 47297-47892 Sentence denotes Paybast et al. [41] RT-PCR NA NA Increased total protein (139 mg/dL), normal glucose and cell count, normal CSF viral serology, negative gram stain and culture Mixed demyelinating and axonal  EMG subtype unknown NA 5 sessions of therapeutic plasma exchange, intravenous bolus of labetalol to control sympathetic nervous system over-reactivity Hydroxychloroquine sulphate 200 mg two times per day for a week Persistence of generalized hyporeflexia, decreased light touch sensation in distal limbs, mild bilateral facial paresis, sympathetic over-reactivity successfully controlled with labetalol,
T368 47893-48139 Sentence denotes Paybast et al. [41] RT-PCR NA NA Albuminocytological dissociation NA NA IVIG 20 g (5 days) Hydroxychloroquine sulphate 200 mg two times per day for a week Persistence of generalized hyporeflexia and decreased light touch sensation in distal limbs
T369 48140-48236 Sentence denotes Pfefferkorn et al. [42] RT-PCR + chest CT NA Negative anti-gangliosides antibodies At admission:
T370 48237-48270 Sentence denotes Normal total protein, cell count:
T371 48271-48300 Sentence denotes 9/µL, negative SARS-CoV-2 PCR
T372 48301-48384 Sentence denotes At day 13th: increased total protein (10.231 mg/L), normal cell count Demyelinating
T373 48385-48519 Sentence denotes AIDP Spinal: massive symmetrical contrast enhancement of the spinal nerve roots at all levels of the spine including the cauda equina.
T374 48520-48784 Sentence denotes Anterior and posterior nerve roots were equally affected IVIG 30 g (5 days) + mechanical invasive ventilation + plasma exchange NA At day 31 from admission: motor improvement with regression of facial and hypoglossal paresis but still needed mechanical ventilation
T375 48785-48850 Sentence denotes Rana et al. [43] RT-PCR NA NA NA Demyelinating with sural sparing
T376 48851-49043 Sentence denotes AIDP Thoracic and lumbar spine: no evidence of myelopathy or radiculopathy IVIG 400 mg/kg (5 days) Hydroxychloroquine and azithromycin On day 4 respiratory improvement, on day 7 rehabilitation
T377 49044-49182 Sentence denotes Reyes-Bueno et al. [44] Serology (negative RT-PCR) NA Negative anti-ganglioside antibodies Increased total protein (70 mg/dl), cell count:
T378 49183-49278 Sentence denotes 5 cells/µl, albuminocytological dissociation Demyelinating with alteration of the Blink-Reflex.
T379 49279-49354 Sentence denotes Further EMG: polyradiculoneuropathy with proximal and brainstem involvement
T380 49355-49493 Sentence denotes AIDP NA IVIG 400 mg/kg (5 days) + Gabapentin NA After the 18th day progressive improvement of  facial and limb paresis, diplopia and pain.
T381 49494-49532 Sentence denotes Consequent neurological rehabilitation
T382 49533-49770 Sentence denotes Riva et al. [45] Chest CT + serology (negative RT-PCR) No pathological findings Negative anti-ganglioside antibodies Normal total protein and cells; negative PCR for SARS-CoV2, EBV, CMV, VZV, HSV 1–2, HIV Demyelinating with sural sparing
T383 49771-49785 Sentence denotes AIDP Brain: NA
T384 49786-49885 Sentence denotes Spinal: no pathological findings IVIG 400 mg/kg (5 days) None Slowly improvement after the 10th day
T385 49886-50021 Sentence denotes Sancho-Saldaña et al. [46] RT-PCR + chest X-Ray NA Negative anti-ganglioside antibodies Increased total protein (0.86 g/L), cell count:
T386 50022-50048 Sentence denotes 3 leucocytes Demyelinating
T387 50049-50217 Sentence denotes AIDP Whole spine: brainstem and cervical meningeal enhancement IVIG 400 mg/kg (5 days) Hydroxychloroquine, azithromycin Recovering by day 7 after the onset of weakness.
T388 50218-50442 Sentence denotes Scheidl et al. [47] RT-PCR No pathological findings Negative Campylobacter Jejuni and Borrelia serology, negative ANA, anti-DNA, c-ANCA,p-ANCA Increased total protein (140 g/L), albuminocytological dissociation Demyelinating
T389 50443-50457 Sentence denotes AIDP Brain: NA
T390 50458-50545 Sentence denotes Cervical spine: no pathological findings IVIG 400 mg/kg (5 days) None Complete recovery
T391 50546-50683 Sentence denotes Sedaghat et al. [48] RT-PCR + chest CT Increased WBC 14.6 × 103 (neutrophils 82.7%, lymphocytes 10.4%) and CRP NA NA Motor sensory Axonal
T392 50684-50721 Sentence denotes AMSAN Brain: no pathological findings
T393 50722-50865 Sentence denotes Spinal: two cervical intervertebral disc herniations IVIG 400 mg/kg (5 days) Hydroxychloroquine, lopinavir/ritonavir, azithromycin Not reported
T394 50866-50926 Sentence denotes Sidig et al. [49] RT-PCR + chest CT NA NA None Demyelinating
T395 50927-51032 Sentence denotes AIDP Brain: no pathological findings NA NA Death after 7 days; because of progressive respiratory failure
T396 51033-51272 Sentence denotes Su et al. [50] RT-PCR + chest X-ray WBC 12,000 cells/µl Negative anti- ganglioside GM1, GD1b and GQ1b antibodies, acetylcholine receptor binding, voltage-gated calcium channel, antinuclear and ANCA Increased total protein (313 mg/dL), WBC:
T397 51273-51293 Sentence denotes 1 cell Demyelinating
T398 51294-51372 Sentence denotes AIDP NA IVIG 2gm/kg (for 4 days) None On day 28 persistence of severe weakness
T399 51373-51477 Sentence denotes Tiet et al. [51] RT-PCR Elevated lactate on venous blood gas (3.3 mmo/L), mildly elevated CRP (20 mg/L).
T400 51478-51527 Sentence denotes Normal WBC, sodium, potassium and renal function.
T401 51528-51601 Sentence denotes NA Increased total protein (> 1.25 g/L), cell count 1x106/L Demyelinating
T402 51602-51777 Sentence denotes AIDP NA IVIG 400 mg/kg/day (5 days) None Resolution of facial diplegia, improved upper and lower limbs weakness; able to mobilize unassisted 11 weaks after neurorehabilitation
T403 51778-51973 Sentence denotes Toscano et al. [52] RT-PCR + Chest CT + serology Lymphocytopenia, increased CRP, LDH, ketonuria Negative anti-ganglioside antibodies Day 2: normal total protein, no cells, negative SARS-CoV-2 PCR
T404 51974-52030 Sentence denotes Day 10: increased total protein (101) mg/dl, cell count:
T405 52031-52087 Sentence denotes 4/mm3, negative SARS-CoV-2 PCR Axonal with sural sparing
T406 52088-52125 Sentence denotes AMSAN Brain: no pathological findings
T407 52126-52133 Sentence denotes Spinal:
T408 52134-52327 Sentence denotes Enhancement of caudal nerve roots IVIG 400 mg/kg (2 cycles) + temporary mechanical non-invasive ventilation Paracetamol At week 4 persistence of severe UL weakness, dysphagia, and LL paraplegia
T409 52328-52534 Sentence denotes Toscano et al. [52] RT-PCR (negative chest CT) Lymphocytopenia; increased ferritin, CRP, LDH NA Increased total protein (123 mg/dl), no cells, negative SARS-CoV-2 PCR Motor sensory axonal with sural sparing
T410 52535-52587 Sentence denotes AMSAN Brain: enhancement of facial nerve bilaterally
T411 52588-52721 Sentence denotes Spinal: no pathological findings IVIG 400 mg/kg Amoxycillin At week 4 improvement of  ataxia and mild improvement of  facial weakness
T412 52722-52927 Sentence denotes Toscano et al. [52] RT-PCR + chest CT Lymphocytopenia; increased CRP, LDH, ketonuria Negative anti-ganglioside antibodies Increased total protein (193 mg/dl), no cells, negative SARS-CoV-2 PCR Motor axonal
T413 52928-52964 Sentence denotes AMAN Brain: no pathological findings
T414 52965-53137 Sentence denotes Spinal: enhancement of caudal nerve roots IVIG 400 mg/kg (2 cycles) + mechanical invasive ventilation Azythromicin ICU admission due to respiratory failure and tetraplegia.
T415 53138-53162 Sentence denotes At week 4 still critical
T416 53163-53329 Sentence denotes Toscano et al. [52] RT-PCR + serology (negative chest CT) Lymphocytopenia; increased CRP, ketonuria NA Normal protein, no cells, negative SARS-CoV-2 PCR Demyelinating
T417 53330-53366 Sentence denotes AIDP Brain: no pathological findings
T418 53367-53472 Sentence denotes Spinal: no pathological findings IVIG 400 mg/kg None At week 4 mild improvement in UL but unable to stand
T419 53473-53810 Sentence denotes Toscano et al. [52] Chest CT + serology (negative RT-PCR in nasopharyngeal swab and BAL) Lymphocytopenia; increased CRP, LDH Negative anti-ganglioside antibodies; negative screening for Campylobacter jejuni, EBV, CMV, HSV, VZV, influenza, HIV Normal total protein (40 mg/dL), white cell count 3/mm3; negative SARS-CoV-2 PCR Demyelinating
T420 53811-53825 Sentence denotes AIDP Brain: NA
T421 53826-54014 Sentence denotes Spinal: no pathological findings IVIG 400 mg/kg + plasma exchange + mechanical invasive ventilation + enteral nutrition None At week 4 flaccid tetraplegia, dysphagia, ventilation dependent
T422 54015-54084 Sentence denotes Velayos Galán et al. [53] RT-PCR + chest X-ray NA NA NA Demyelinating
T423 54085-54215 Sentence denotes AIDP NA IVIG 400 mg/kg (5 days) Hydroxychloroquine, lopinavir/ritonavir, amoxicillin, corticosteroids + low-flow oxygen therapy NA
T424 54216-54311 Sentence denotes Virani et al. [54] rt-pcr + chest mrt WBC 8.6 × 103; Hb 15.4 g/dl; PC 211 × 103; procalcitonin:
T425 54312-54341 Sentence denotes 0.15 ng/ml NA NA NA Brain: NA
T426 54342-54631 Sentence denotes Spinal: no pathological findings IVIG 400 mg/kg (5 days) + mechanical invasive ventilation (4 days) Hydroxychloroquine 400 mg bid for first 2 doses, then 200 mg bid for 8 doses At day 4 of IVIG: liberation from mechanical ventilation, resolution of UL symptoms, persistence of LL weakness.
T427 54632-54665 Sentence denotes Sent to a rehabilitation facility
T428 54666-55016 Sentence denotes Webb et al. [55] RT-PCR + chest X-ray + chest CT Lymphopenia (0.9 × 109/L), thrombocytosis (490 × 109/L) raised CRP (25 mg/L) Negative ANA, ANCA, anti-ganglioside antibodies, syphilis serology HIV, hepatitis B and hepatitis C Increased total protein (0.51 g/L), normal glucose and cell count, negative SARS-CoV-2 PCR, negative viral PCR Demyelinating
T429 55017-55074 Sentence denotes AIDP NA IVIG 400 mg/kg/day (5 days) + Mechanical invasive
T430 55075-55158 Sentence denotes ventilation Co-amoxiclav After 1 week in ICU: no oxygen requirement and ventilation
T431 55159-55299 Sentence denotes Zhao et al. [56] RT-PCR + chest CT WBC 0.52 × 109; PC 113 × 109/L NA Increased total protein (124 mg/dL), cell count 5 × 106/L Demyelinating
T432 55300-55426 Sentence denotes AIDP NA IVIG (dosing not reported) Arbidol, lopinavir/ ritonavir At day 30 resolution of neurological and respiratory symptoms
T433 55427-56658 Sentence denotes AIDP, acute inflammatory demyelinating polyneuropathy; AMAN, acute motor axonal neuropathy; AMSAN, acute motor sensory axonal neuropathy; ANA, antinuclear antibodies; ANCA, anti-neutrophil cytoplasmic antibodies; BAL, bronchoalveolar lavage; CK, creatine kinase; CMV, cytomegalovirus; COPD, chronic obstructive pulmonary disease, COVID-19, coronavirus disease 2019; CRP, C-reactive protein; CSF, cerebrospinal fluid; CT, computed tomography; DM, diabetes mellitus; EBV, Epstein–Barr virus; ESR, erythrocyte sedimentation rate; F, female; GBS, Guillain–Barré syndrome; GGT, gamma-glutamyl transferase; GOT, glutamic oxaloacetic transaminase; GPT, glutamate pyruvate transaminase; Hb, haemoglobin; HIV, human immunodeficiency virus; HSV, herpex simplex virus; ICU, intensive-care unit; IL, interleukin; IVIG, intravenous immunoglobulins; IL, interleukin; LDH, lactate dehydrogenase; LL, lower limbs; M, male; MRI, magnetic resonance imaging; NA, not available; PC, platelet count; PCR, Polymerase Chain Reaction; SARS-CoV-2, severe acute respiratory syndrome coronavirus-2; TNF, tumor necrosis factor; UL, upper limbs; VDRL, Veneral Disease Research Laboratory; VZV, varicella-zoster virus; WBC, white blood cells; X-ray: radiography
T434 56659-56879 Sentence denotes aTime to Nadir refers to days elapsed between the onset of neurological symptoms and the development of the worst clinical picture when no progression was reported nadir was considered concomitant with GBS symptoms onset
T435 56880-56927 Sentence denotes bAccording to Brighton diagnostic criteria [66]